MedTrace Logo

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

NCT01570972 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2020-05-21

No results posted yet for this study

Summary

Multifamily group psychoeducation \[MFG\] and group cognitive behavioral therapy \[GCBT\] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect-some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Bipolar Disorder With Psychotic Features
  • Major Depression With Psychotic Features
  • Psychotic Disorder Not Otherwise Specified (NOS)

Interventions

BEHAVIORAL

Group Cognitive Behavioral Therapy

weekly

BEHAVIORAL

Multifamily Group Psychoeducation

twice monthly

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Nicholas Breitborde, Ph.D. · The Ohio State Univerity

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2017-04-30
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01570972 on ClinicalTrials.gov